Mesoblast (MESO) Earnings Date & Reports

Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MESO is expected to report earnings to fall 366.67% to 7 cents per share on November 25

Q3'26

Est.

$0.08

Q1'26

Est.

$-0.03

Q4'25

Beat

by $0.04

Q3'25

Beat

by $0.03

Q2'25

Beat

by $0.36

The last earnings report on June 02 showed earnings per share of -2 cents, meeting the estimate of -2 cents. With 80.48K shares outstanding, the current market capitalization sits at 2.01B.

View a ticker or compare two or three

MESO

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days